» Articles » PMID: 16931570

Role of the N-terminal Activation Domain of the Coiled-coil Coactivator in Mediating Transcriptional Activation by Beta-catenin

Overview
Journal Mol Endocrinol
Date 2006 Aug 26
PMID 16931570
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The coiled-coil coactivator (CoCoA) is involved in transcriptional activation of target genes by nuclear receptors and the xenobiotic aryl hydrocarbon receptor, as well as target genes of the Wnt signaling pathway, which is mediated by the lymphocyte enhancer factor (LEF)/T cell factor transcription factors and the coactivator beta-catenin. The recruitment of CoCoA by nuclear receptors is accomplished by the interaction of the central coiled-coiled domain of CoCoA with p160 coactivators; the C-terminal activation domain (AD) of CoCoA is used for downstream signaling, whereas the function of the N-terminal region is undefined. Here we report that the N terminus of CoCoA contains another AD, which is necessary and sufficient for synergistic activation of LEF1-mediated transcription by CoCoA and beta-catenin. The N-terminal AD contains a p300 binding motif, which is important for synergistic cooperation of CoCoA and p300 as coactivators for LEF1 and beta-catenin. p300 contributes to the function of the CoCoA N-terminal AD primarily through its histone acetyltransferase activity. Moreover, in cultured cells, endogenous p300 is recruited to the promoter of an integrated reporter gene by the N terminus of CoCoA. Thus, the coactivator function of CoCoA for nuclear receptors and LEF1/beta-catenin involves differential utilization of two different CoCoA ADs.

Citing Articles

ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum.

Reggiori F, Molinari M Physiol Rev. 2022; 102(3):1393-1448.

PMID: 35188422 PMC: 9126229. DOI: 10.1152/physrev.00038.2021.


Genome wide study of tardive dyskinesia in schizophrenia.

Lim K, Lam M, Zai C, Tay J, Karlsson N, Deshpande S Transl Psychiatry. 2021; 11(1):351.

PMID: 34103471 PMC: 8187404. DOI: 10.1038/s41398-021-01471-y.


Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagy.

Stefely J, Zhang Y, Freiberger E, Kwiecien N, Thomas H, Davis A Autophagy. 2020; 16(12):2219-2237.

PMID: 31971854 PMC: 7751563. DOI: 10.1080/15548627.2020.1719746.


Development and optimization of OspC chimeritope vaccinogens for Lyme disease.

Izac J, OBier N, Oliver Jr L, Camire A, Earnhart C, LeBlanc Rhodes D Vaccine. 2020; 38(8):1915-1924.

PMID: 31959423 PMC: 7085410. DOI: 10.1016/j.vaccine.2020.01.027.


Competition between two high- and low-affinity protein-binding sites in myosin VI controls its cellular function.

Fili N, Hari-Gupta Y, Aston B, Dos Santos A, Gough R, Alamad B J Biol Chem. 2019; 295(2):337-347.

PMID: 31744880 PMC: 6956527. DOI: 10.1074/jbc.RA119.010142.


References
1.
Song L, Gelmann E . Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor. J Biol Chem. 2005; 280(45):37853-67. DOI: 10.1074/jbc.M503850200. View

2.
Tjian R, Maniatis T . Transcriptional activation: a complex puzzle with few easy pieces. Cell. 1994; 77(1):5-8. DOI: 10.1016/0092-8674(94)90227-5. View

3.
Kim J, Yang C, Stallcup M . Downstream signaling mechanism of the C-terminal activation domain of transcriptional coactivator CoCoA. Nucleic Acids Res. 2006; 34(9):2736-50. PMC: 1464418. DOI: 10.1093/nar/gkl361. View

4.
Morin P . beta-catenin signaling and cancer. Bioessays. 1999; 21(12):1021-30. DOI: 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P. View

5.
Takemaru K, Moon R . The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. J Cell Biol. 2000; 149(2):249-54. PMC: 2175158. DOI: 10.1083/jcb.149.2.249. View